Earnings Feed
Start Free
Home/Filings/4/0001354488-17-000268
4//SEC Filing

CorMedix Inc. 4

Accession 0001354488-17-000268

$CRMDCIK 0001410098operating
View on SEC.govCompany Profile

Filed

Feb 14, 7:00 PM ET

Accepted

Feb 15, 4:02 PM ET

Size

20.6 KB

Accession

0001354488-17-000268

Insider Transaction Report

Form 4
Period: 2017-02-14
CorMedix Inc.CRMD
GEORGE MICHAEL W
Director
Transactions
  • Purchase

    Phantom Stock

    2017-02-14$7500.00/sh+3,472$26,040,000→ 3,472 total
    Exercise: $0.00→ Common Stock (3,472 underlying)
Holdings

  • Stock Option (Right to Buy Common Stock)

    Exercise: $2.11Exp: 2024-04-05→ Common Stock (15,000 underlying)
    15,000

  • Phantom Stock

    Exercise: $0.00→ Common Stock (2,459 underlying)
    2,459

  • Phantom Stock

    Exercise: $0.00→ Common Stock (3,125 underlying)
    3,125

  • Stock Option (Right to Buy Common Stock)

    Exercise: $1.91Exp: 2026-02-21→ Common Stock (90,000 underlying)
    90,000

  • Phantom Stock

    Exercise: $0.00→ Common Stock (2,767 underlying)
    2,767

  • Phantom Stock

    Exercise: $0.00→ Common Stock (4,143 underlying)
    4,143

  • Phantom Stock

    Exercise: $0.00→ Common Stock (1,176 underlying)
    1,176

  • Phantom Stock

    Exercise: $0.00→ Common Stock (3,968 underlying)
    3,968

  • Stock Option (Right to Buy Common Stock)

    Exercise: $2.79Exp: 2024-02-27→ Common Stock (30,000 underlying)
    30,000

  • Stock Option (Right to Buy Common Stock)

    Exercise: $5.62Exp: 2025-03-01→ Common Stock (50,000 underlying)
    50,000

  • Phantom Stock

    Exercise: $0.00→ Common Stock (1,847 underlying)
    1,847

  • Phantom Stock

    Exercise: $0.00→ Common Stock (4,335 underlying)
    4,335
Footnotes (4)
  • [F1]Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.
  • [F2]These shares were credited automatically to the reporting person's account pursuant to the reporting person's election to defer the receipt of cash compensation of directors' fees.
  • [F3]5,000 shares vest upon completion of the April 2014 milestone, 10,000 shares vest upon completion of another milestone by the third quarter of 2014.
  • [F4]These options vest in full on the first anniversary of the date of grant.

Documents

1 file

Issuer

CorMedix Inc.

CIK 0001410098

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001410098

Filing Metadata

Form type
4
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:02 PM ET
Size
20.6 KB
View on SEC.gov